Elevated Lipoprotein(a) Clinical Trials in Sherman, Texas

Home | Studies | Elevated Lipoprotein(a) Clinical Trials

Living with elevated lipoprotein(a), also known as Lp(a)?

You may be at increased risk for cardiovascular disease.

Lp(a) is a cholesterol-carrying particle in the blood that is largely determined by genetics. High levels of Lp(a) are associated with a higher risk of atherosclerotic cardiovascular disease (ASCVD), including heart attack, stroke, and peripheral artery disease. Unlike other lipids, Lp(a) levels are not significantly reduced by lifestyle changes or standard cholesterol-lowering therapies.

Revival Research Institute is conducting elevated lipoprotein(a) clinical trials to explore investigational therapies. These studies aim to evaluate the safety and effectiveness of treatments that may lower Lp(a) levels and reduce cardiovascular risk. If you are in Texas, you may be eligible to participate in an elevated lipoprotein(a) clinical trial in Sherman, TX.

Are You Eligible to Participate?

To be eligible for our clinical trial for high lipoprotein(a), individuals must meet the following criteria:

Male or female, aged 18 years or older
Documented elevated lipoprotein(a) levels above the clinical threshold
Additional cardiovascular risk factors such as existing ASCVD or a family history of premature heart disease

*Additional criteria may apply.

Participation in elevated lipoprotein(a) clinical trials provides a chance to receive expert care, free study-related medication, and regular health monitoring by experienced medical professionals.

"*" indicates required fields

Company

This field is for validation purposes and should be left unchanged.

Who is this information for?**

A Family Member

A Friend

My Patient

Please provide YOUR contact information only.

Name*

Phone Number*

Best Time to Call*

Morning

Middle of the day

Evening

Select State*

How did you hear about us?*

Comments

User Agreement*

By checking this box, you agree to receive SMS messages from Revival Research Institute. You may reply STOP to opt-out at any time. Reply HELP at any time. Messages and data rates may apply. Message frequency will vary.

By checking this form, I consent to receiving phone calls from Revival Research Institute, LLC.

This is our Privacy Policy.

Elevated Lipoprotein (a) Clinical Trials Flyer

About the Clinical Trials for Elevated Lp(a)

Elevated Lp(a) is a genetic lipid disorder that cannot be controlled through diet or exercise. It contributes to the buildup of plaque in arteries, which can narrow or block blood flow, leading to serious cardiovascular events.

Revival Research Institute is conducting elevated lipoprotein(a) clinical trials to investigate an investigational therapy targeting Lp(a). The goal is to assess long-term safety, tolerability, and efficacy in lowering Lp(a) levels and reducing cardiovascular complications.

The study includes:

Screening for baseline Lp(a) levels
Randomization to investigational treatment or placebo
Regular follow-ups for laboratory tests, imaging, and cardiovascular assessments

All study-related procedures and treatments, including the investigational drug, are provided at no cost. Insurance is not required, and participants may receive compensation for time and travel.

Get Started: What to Expect?

If you are living with elevated lipoprotein(a), you may qualify for a paid clinical trial exploring potential treatment options. After completing the interest form, a research team member will contact you for a brief pre-screening to review your health history and eligibility.

If you qualify, you will be asked to review and sign an Informed Consent Form (ICF) that explains the study procedures, potential benefits, and risks.

Following your consent, you’ll be invited to a screening visit at our clinical research site. During this visit, medical staff will review your history, perform physical exams, and run lab tests to confirm eligibility. If you meet all study requirements, you will be officially enrolled in the trial.

Our team will ensure you fully understand your role in the study and what to expect throughout the process. You are encouraged to ask questions before enrolling. Your participation helps advance future treatments for elevated Lp(a).

Age

18 years or older

Condition